- High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
-
Suh JM, Yoo KH, Sung KW, Kim JY, Cho EJ, Koo HH, Lee SK, Kim J, Lim DH, Suh YL, Kim DW
- KMID: 1779200
- J Korean Med Sci.
- 2009 Aug;24(4):660-667.
- doi: 10.3346/jkms.2009.24.4.660
High-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR) was applied to improve the prognosis of patients with high-risk stage 3 neuroblastoma. From January 1997 to December 2006, 28 patients were... -
- CITED
-
- Close
- SHARE
-
- Close
